Vai al contenuto principale della pagina
Titolo: | Drug safety: FDA's future inspection plans need to address issues presented by COVID-19 backlog : testimony before the Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, Committee on Appropriations, House of Representatives / / statement of Mary Denigan-Macauley |
Pubblicazione: | [Washington, D.C.] : , : United States Government Accountability Office, , 2021 |
Descrizione fisica: | 1 online resource (18 pages) : color illustrations, color map |
Soggetto topico: | COVID-19 (Disease) - Treatment - United States |
COVID-19 Pandemic, 2020- - United States | |
Drugs - Inspection - United States | |
Drugs - United States - Safety measures | |
Drug reimportation - United States | |
Persona (resp. second.): | Denigan-MacauleyMary |
Note generali: | "For release on delivery, expected at 10:00 a.m. ET, Thursday, March 4, 2021." |
Nota di bibliografia: | Includes bibliographical references. |
Altri titoli varianti: | Drug safety |
Titolo autorizzato: | Drug safety: FDA's future inspection plans need to address issues presented by COVID-19 backlog |
Formato: | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione: | Inglese |
Record Nr.: | 9910715327503321 |
Lo trovi qui: | Univ. Federico II |
Opac: | Controlla la disponibilità qui |